- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.04. | Rallybio discontinues lead drug for rare maternal disorder | ||
| 08.04. | Tango Therapeutics cuts nearly one-fifth of staff | ||
| 08.04. | Judge permanently blocks Trump admin plan to cap NIH funding, setting up appeals battle | ||
| 07.04. | RFK Jr. won't appear before Senate panel this week | ||
| 07.04. | GSK targets neurodegenerative diseases with latest licensing deal | ||
| 07.04. | Obesity drug data helps Rhythm defy market slide | ||
| 07.04. | Trump rejects Biden-era plan to let Medicare cover obesity drugs | ||
| 04.04. | Tariffs send healthcare industry into 'unchartered waters' | ||
| 04.04. | Trial monitors recommend Elevidys studies continue; Novartis kidney drug approved | ||
| 04.04. | M&A recap: Big pharma starts the year mostly avoiding billion-dollar deals | ||
| 03.04. | Roche halts testing of Sarepta Duchenne gene therapy in Europe | ||
| 03.04. | FDA misses approval deadline for Novavax's COVID-19 vaccine | ||
| 03.04. | Biotech 'megarounds' hold steady as startups, VCs wait on IPOs | ||
| 03.04. | Trump installs sweeping new tariffs, but pharma appears to dodge blow | ||
| 02.04. | Leqembi's EU review drags on; Sanofi gets a new development head | ||
| 02.04. | 'A cruel April Fool's joke': HHS layoffs characterized by confusion, errors | ||
| 02.04. | FDA device office hit in HHS layoffs | ||
| 02.04. | Newly launched genetic medicine CDMO acquires Landmark Bio | ||
| 01.04. | HHS begins layoffs in chaotic fashion | ||
| 01.04. | Judge overturns FDA's lab developed test regulation, siding with industry | ||
| 01.04. | RNA editing biotech Airna adds $155M in funding | ||
| 31.03. | Cell, gene therapy makers lose a champion at FDA with exit of Peter Marks | ||
| 31.03. | Isomorphic raises $600M on big ambitions for AI drugmaking tech | ||
| 31.03. | FDA official's ouster sends shares of vaccine makers sliding | ||
| 31.03. | Lilly study data reinforce potential of new kind of heart drug |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
